Gain Therapeutics Inc (GANX)
2.43
-0.07
(-2.80%)
USD |
NASDAQ |
May 22, 16:00
2.43
0.00 (0.00%)
After-Hours: 20:00
Gain Therapeutics Total Assets (Quarterly): 14.58M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.58M |
| December 31, 2023 | 18.61M |
| September 30, 2023 | 14.10M |
| June 30, 2023 | 18.26M |
| March 31, 2023 | 21.32M |
| December 31, 2022 | 24.10M |
| September 30, 2022 | 28.33M |
| Date | Value |
|---|---|
| June 30, 2022 | 31.89M |
| March 31, 2022 | 37.60M |
| December 31, 2021 | 38.99M |
| September 30, 2021 | 42.56M |
| June 30, 2021 | 45.35M |
| March 31, 2021 | 48.04M |
| December 31, 2020 | 9.604M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.604M
Minimum
Dec 2020
48.04M
Maximum
Mar 2021
28.09M
Average
26.21M
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 63.94B |
| Alpine Immune Sciences Inc | 373.65M |
| Outlook Therapeutics Inc | 59.03M |
| OptiNose Inc | 83.71M |
| Greenwich LifeSciences Inc | 5.510M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.935M |
| Shareholders Equity (Quarterly) | 8.642M |